MedTrace Logo

Validation of a Simple and Cost-Effective Nucleic Acid Test for HIV Detection

NCT01084954 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2016-06-16

No results posted yet for this study

Summary

Validate a simple and cost-effective Nucleic Acid Test for HIV Detection in order to develop a rapid, highly sensitive and specific, one-stage test for the diagnosis of HIV infection. Blood samples collected will be assayed using the BioHelix Corporation helicase-dependent amplification or the Cepheid Xpert HIV-1 Quant Assay. A false negative or false positive rate of \>1.0% would make this test unacceptable as a screening test for HIV viremia.

Conditions

  • HIV
  • HIV Infections

Sponsors & Collaborators

  • George Washington University

    lead OTHER

Principal Investigators

  • Gary Simon, M.D., Ph.D. · George Washington University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2016-04-30
Completion
2016-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01084954 on ClinicalTrials.gov